Glenn A Wintemute Net Worth

The estimated Net Worth of Glenn A Wintemute is at least $25.3 Millón dollars as of 1 June 2010. Glenn Wintemute owns over 10,500 units of American Vanguard stock worth over $6,446,091 and over the last 21 years Glenn sold AVD stock worth over $18,876,351.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Glenn Wintemute AVD stock SEC Form 4 insiders trading

Glenn has made over 41 trades of the American Vanguard stock since 2004, according to the Form 4 filled with the SEC. Most recently Glenn sold 10,500 units of AVD stock worth $82,740 on 1 June 2010.

The largest trade Glenn's ever made was selling 220,000 units of American Vanguard stock on 11 July 2005 worth over $4,400,000. On average, Glenn trades about 21,358 units every 44 days since 2003. As of 1 June 2010 Glenn still owns at least 1,061,959 units of American Vanguard stock.

You can see the complete history of Glenn Wintemute stock trades at the bottom of the page.

What's Glenn Wintemute's mailing address?

Glenn's mailing address filed with the SEC is , , , , .

Insiders trading at American Vanguard

Over the last 21 years, insiders at American Vanguard have traded over $50,676,664 worth of American Vanguard stock and bought 629,726 units worth $5,875,021 . The most active insiders traders include Glenn A Wintemute, Eric G Wintemute y Herbert A Kraft. On average, American Vanguard executives and independent directors trade stock every 29 days with the average trade being worth of $98,474. The most recent stock trade was executed by Keith M Cruiser Capital Adv... on 30 August 2024, trading 136,492 units of AVD stock currently worth $790,289.

What does American Vanguard do?

american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196

Complete history of Glenn Wintemute stock trades at American Vanguard

American Vanguard executives and stock owners

American Vanguard executives and other stock owners filed with the SEC include:

• Eric Wintemute,
  Chairman of the Board, Chief Executive Officer
• Eric G. Wintemute,
  Chairman & CEO
• David Johnson,
  Chief Financial Officer, Vice President, Treasurer
• Ulrich Trogele,
  Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation
• Timothy Donnelly,
  Chief Administrative Officer, General Counsel, Secretary
• Dr. Ulrich G. Trogele Ph.D.,
  COO & Exec. VP
• Peter Eilers,
  Managing Director, Amvac Netherlands BV
• Timothy J. Donnelly Esq.,
  Gen. Counsel, Chief Admin. Officer & Sec.
• David T. Johnson,
  VP, CFO & Treasurer
• Anthony Hendrix,
  Senior Vice President - Crop Sales for U.S. & Canada
• Timothy J. Donnelly,
  Gen. Counsel, Chief Admin. Officer & Sec.
• Peter E. Eilers,
  Managing Director of AMVAC Netherlands BV
• Anthony Hendrix,
  Sr. VP of Crop Sales for U.S. & Canada
• John Killmer,
  Lead Independent Director
• Alfred Ingulli,
  Independent Director
• Morton Erlich,
  Independent Director
• Lawrence Clark,
  Independent Director
• M. Esmail Zirakparvar,
  Independent Director
• Scott Baskin,
  Independent Director
• Debra Edwards,
  Independent Director
• Emer Gunter,
  Independent Director
• William Kuser,
  Director of Investor Relations
• James Thompson,
  Director of Bus. Devel., Portfolio Management Biologicals & Non-Crop
• Robert F. Gilbane,
  Pres of Gemchem Inc
• Smith Cindy Baker,
  See Remarks
• Jong Ad De,
  MD AMVAC Netherlands BV
• John Rizzi,
  VP Operations (AMVAC)
• Anne Turnbough,
  See Remarks
• Steven D Macicek,
  
• Suneet Ranganath,
  See Remarks
• Peter Porpiglia,
  See Remarks
• Jean Pougnier,
  VP Business Dev. & Marketing
• Brett R Meinsen,
  VICE PRESIDENT
• Mark H Blincoe,
  VP/Chief Adm. Officer
• Jay R Harris,
  Director
• Carl R Soderlind,
  Director
• Keith M Cruiser Capital Adv...,
  
• James Lehman,
  Vice Pres of Sales Amvac Chem
• Glen D Johnson,
  Sr.VP AMVAC Chem. Corp.
• Jerome L Coben,
  Director
• Irving J Thau,
  Director
• Herbert A Kraft,
  Director
• Glenn A Wintemute,
  Director
• Trevor Thorley,
  COO & EVP of Amvac Chemical
• James A Barry,
  Sr. VP, CFO & Sec/Trsr
• Robert F Gilbane,
  President of GemChem, Inc.
• Christopher Hildreth,
  Sr. VP of AMVAC Chemical Corp.
• John B Miles,
  Director
• Doug Ashmore,
  VICE PRESIDENT MFG- AMVAC
• Johann Venter,
  See Remarks
• Patrick E Gottschalk,
  
• Marisol Angelini,
  
• Shayne M Wetherall,
  CEO, AMGUARD
• Andrew B Naughton,
  V.P., Director of Technology
• Keith M Rosenbloom,
  
• Mark R Bassett,
  
• John Mason Bennett,
  VP US Crop Sales